| Akcje insidera | 354 830 574 shares |
Wynik sentymentu insiderów
Ocena sentymentu insiderów pokazuje firmy, które są kupowane przez insiderów korporacyjnych.
Jest to wynik zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje spółki o najwyższym poziomie akumulacji informacji poufnych. Model rankingowy wykorzystuje kombinację liczby netto insiderów kupujących w ciągu ostatnich 90 dni, całkowitej liczby akcji kupionych jako procent akcji w obrocie oraz całkowitej liczby akcji posiadanych przez insiderów. Liczba ta waha się od 0 do 100, przy czym wyższe liczby wskazują na wyższy poziom akumulacji w porównaniu z innymi spółkami, a 50 to średnia.
Częstotliwość aktualizacji: codziennie
Ocena sentymentu kadry kierowniczej
Ocena sentymentu kadry kierowniczej pokazuje, że firmy są kupowane przez urzędników korporacyjnych.
Z definicji dyrektorzy korporacyjni to insiderzy korporacyjni, ale w przeciwieństwie do niektórych innych insiderów (10% akcjonariuszy i członków zarządu), dyrektorzy pracują dla firmy na co dzień i podczas handlu korzystają z własnych pieniędzy. (10% Akcjonariusze i członkowie zarządu często zarządzają funduszami zarządzających pieniędzmi innych osób). W związku z tym transakcje wykorzystujące informacje poufne dokonywane przez osoby z kadry kierowniczej mają znacznie większe znaczenie i powinny być odpowiednio traktowane.
Podobnie jak ocena sentymentu insiderów, ocena sentymentu kadry kierowniczej jest wynikiem zaawansowanego, wieloczynnikowego modelu ilościowego, który identyfikuje firmy o najwyższym poziomie akumulacji urzędników.
Częstotliwość aktualizacji: codziennie
Kluczowe wskaźniki insider
Ta karta pokazuje pozycję firmy według różnych wskaźników insider. Ranking według miary percentyla pokazuje, jak ta firma wypada na tle innych firm na rynkach amerykańskich. Wyższe rankingi wskazują na lepszą sytuację.
Na przykład ogólnie przyjmuje się, że kupowanie przez insiderów jest pozytywnym wskaźnikiem, zatem spółki z większą liczbą takich transakcji plasowałyby się wyżej niż spółki z mniejszą liczbą takich transakcji (lub nawet sprzedaży przez insiderów.
Liczba netto zakupów dokonanych przez insiderów (ranking)
N/A
Liczba netto zakupów dokonanych przez insiderów to łączna liczba insiderów kupujących pomniejszona o całkowitą liczbę insiderów sprzedających w ciągu ostatnich 90 dni. Tutaj pokazana jest miara percentyla (zakres od 0 do 100%).
Procent akcji kupowanych przez insiderów (ranking)
N/A
Procent akcji zakupionych przez insiderów to całkowita liczba akcji zakupionych przez insiderów pomniejszona o całkowitą liczbę akcji sprzedanych przez insiderów w ciągu ostatnich 90 dni, podzielona przez całkowitą liczbę akcji zakupionych przez insiderów i pomnożona przez 100.
Wykres handlu insider
Poniższy wykres przedstawia Myovant Sciences Ltd transakcji zrealizowanych przez insiderów. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Ogólnie rzecz biorąc, dokonywanie transakcji w ich firmach przez osoby posiadające dostęp do informacji poufnych w oparciu o istotne, niepubliczne informacje jest generalnie nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4.
Lista insiderów i wskaźniki rentowności
Ta tabela przedstawia listę znanych insiderów i jest generowana automatycznie na podstawie zgłoszeń ujawnianych SEC. Oprócz nazwisk, najnowszego tytułu oraz oznaczenia dyrektora, członka kierownictwa lub 10% właściciela, podajemy najnowsze ujawnione pakiety akcji. Dodatkowo, jeśli to możliwe, udostępniamy historyczne wyniki handlowe danego insidera. Historyczne wyniki handlowe to średnia ważona wyników rzeczywistych transakcji zakupu na otwartym rynku dokonanych przez insiderów. Więcej informacji na temat sposobu obliczania tej wartości obejrzyj webinar na YouTube.
See our leaderboard of most profitable insider traders.
| Insider | Średni zysk (%) | Posiadane Akcje |
Podział korygujący |
|---|
Report errors via our new Insider Auditing Tool
Śledź historię zakupów insiderów — analiza zysków krótkoterminowych
W tej sekcji analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w MYOV / Myovant Sciences Ltd. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Śledź historię sprzedaży insider — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży insidera na otwartym rynku dokonanej w MYOV / Myovant Sciences Ltd. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji wyniki są teoretyczne .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia transakcji
Kliknij ikonę linku, aby zobaczyć pełną historię transakcji. Transakcje zgłoszone w ramach automatycznego planu handlowego 10b5-1 będą oznaczone znakiem X w kolumnie oznaczonej 10b-5.
| Plik Data |
Data transakcji |
Formularz | Wtajemniczony | Serce | Nazwa papieru wartościowego | Kod | Bezpośredni | Cena wykonania |
Cena jednostki |
Zmieniono jednostki |
Zmieniona wartość (1 tys.) |
Pozostałe opcje |
Pozostałe akcje |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-10 | 2023-03-10 | 4 | POTTER MYRTLE S | MYOV | Common Shares | D | -3 673 | 0 | ||||||
| 2023-03-10 | 2023-03-10 | 4 | Valente Nancy | MYOV | Common Shares | D | -3 673 | 0 | ||||||
| 2023-03-10 | 2023-03-10 | 4 | Mehra Uneek | MYOV | Common Shares | D | -181 972 | 0 | ||||||
| 2023-03-10 | 2023-03-10 | 4 | Mehra Uneek | MYOV | Common Shares | D | -20 724 | 181 972 | ||||||
| 2023-03-10 | 2023-03-10 | 4 | Merendino Lauren | MYOV | Common Shares | D | -147 747 | 0 | ||||||
| 2023-03-10 | 2023-03-10 | 4 | Merendino Lauren | MYOV | Common Shares | D | -21 791 | 147 747 | ||||||
| 2023-03-10 | 2023-03-10 | 4 | Lang Matthew | MYOV | Common Shares | D | -241 158 | 0 | ||||||
| 2023-03-10 | 2023-03-10 | 4 | Lang Matthew | MYOV | Common Shares | D | -113 145 | 241 158 | ||||||
| 2023-03-10 | 2023-03-10 | 4 | Marek David C | MYOV | Common Shares | D | -321 924 | 0 | ||||||
| 2023-03-10 | 2023-03-10 | 4 | Marek David C | MYOV | Common Shares | D | -95 675 | 321 924 | ||||||
| 2023-03-10 | 2023-03-10 | 4 | GUINAN MARK | MYOV | Common Shares | D | -3 673 | 0 | ||||||
| 2023-03-10 | 2023-03-10 | 4 | Gulfo Adele M. | MYOV | Common Shares | D | -3 673 | 0 | ||||||
| 2023-03-10 | 2023-03-10 | 4 | Curran Terrie | MYOV | Common Shares | D | -3 673 | 0 | ||||||
| 2023-03-10 | 2023-03-10 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | -160 082 | 0 | ||||||
| 2023-03-10 | 2023-03-10 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | -86 602 | 160 082 | ||||||
| 2023-03-10 | 2023-03-10 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Shares | I | 27,0000 | 51 599 200 | 1 393 178 | 45 798 176 | ||||
| 2023-03-06 | 2023-03-03 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Shares | I | -4 243 005 | 45 798 176 | ||||||
| 2023-01-20 | 2023-01-18 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 26,8900 | -1 109 | -30 | 246 684 | ||||
| 2023-01-20 | 2023-01-18 | 4 | Marek David C | MYOV | Common Shares | D | 26,8900 | -8 037 | -216 | 417 599 | ||||
| 2023-01-20 | 2023-01-18 | 4 | Merendino Lauren | MYOV | Common Shares | D | 26,8900 | -2 008 | -54 | 169 538 | ||||
| 2023-01-20 | 2023-01-18 | 4 | Lang Matthew | MYOV | Common Shares | D | 26,8900 | -1 272 | -34 | 354 303 | ||||
| 2023-01-05 | 2023-01-04 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 26,9000 | -2 251 | -61 | 247 793 | ||||
| 2023-01-05 | 2023-01-04 | 4 | Lang Matthew | MYOV | Common Shares | D | 26,9000 | -2 779 | -75 | 355 575 | ||||
| 2022-12-20 | 2022-12-16 | 4 | Mehra Uneek | MYOV | Common Shares | D | 26,7500 | -2 241 | -60 | 202 696 | ||||
| 2022-10-28 | 2022-10-26 | 4 | Curran Terrie | MYOV | Common Shares | D | 9 859 | 9 859 | ||||||
| 2022-10-28 | 2022-10-26 | 4 | GUINAN MARK | MYOV | Common Shares | D | 9 859 | 9 859 | ||||||
| 2022-10-28 | 2022-10-26 | 4 | Gulfo Adele M. | MYOV | Common Shares | D | 9 859 | 9 859 | ||||||
| 2022-10-28 | 2022-10-26 | 4 | POTTER MYRTLE S | MYOV | Common Shares | D | 9 859 | 9 859 | ||||||
| 2022-10-28 | 2022-10-26 | 4 | Valente Nancy | MYOV | Common Shares | D | 9 859 | 9 859 | ||||||
| 2022-10-21 | 3 | Nishinaka Shigeyuki | MYOV | Common Shares | D | 0 | ||||||||
| 2022-10-20 | 2022-10-18 | 4 | Merendino Lauren | MYOV | Common Shares | D | 25,2000 | -1 703 | -43 | 171 546 | ||||
| 2022-10-20 | 2022-10-18 | 4 | Marek David C | MYOV | Common Shares | D | 25,2000 | -11 156 | -281 | 425 636 | ||||
| 2022-10-20 | 2022-10-18 | 4 | Lang Matthew | MYOV | Common Shares | D | 25,2000 | -1 933 | -49 | 358 354 | ||||
| 2022-10-20 | 2022-10-18 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 25,2000 | -1 604 | -40 | 250 044 | ||||
| 2022-10-06 | 2022-10-04 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 24,4000 | -2 738 | -67 | 251 648 | ||||
| 2022-10-06 | 2022-10-04 | 4 | Lang Matthew | MYOV | Common Shares | D | 24,4000 | -3 679 | -90 | 360 287 | ||||
| 2022-09-20 | 2022-09-16 | 4 | Mehra Uneek | MYOV | Common Shares | D | 18,8600 | -9 243 | -174 | 204 937 | ||||
| 2022-08-16 | 2022-08-15 | 4 | Lang Matthew | MYOV | Common Shares | D | 18,2300 | -31 214 | -569 | 363 966 | ||||
| 2022-08-16 | 2022-08-12 | 4 | Lang Matthew | MYOV | Common Shares | D | 124 780 | 395 180 | ||||||
| 2022-07-20 | 2022-07-18 | 4 | Merendino Lauren | MYOV | Common Shares | D | 12,8700 | -1 704 | -22 | 173 249 | ||||
| 2022-07-20 | 2022-07-18 | 4 | Lang Matthew | MYOV | Common Shares | D | 12,8700 | -1 935 | -25 | 270 400 | ||||
| 2022-07-20 | 2022-07-18 | 4 | Marek David C | MYOV | Common Shares | D | 12,8700 | -11 164 | -144 | 436 792 | ||||
| 2022-07-20 | 2022-07-18 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 12,8700 | -1 606 | -21 | 254 386 | ||||
| 2022-07-08 | 2022-07-06 | 4 | Lang Matthew | MYOV | Common Shares | D | 13,4000 | -3 702 | -50 | 272 335 | ||||
| 2022-07-08 | 2022-07-06 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 13,4000 | -2 755 | -37 | 255 992 | ||||
| 2022-06-01 | 2022-05-27 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 10,0700 | -1 382 | -14 | 258 747 | ||||
| 2022-04-21 | 2022-04-19 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 10,4500 | -4 632 | -48 | 260 129 | ||||
| 2022-04-21 | 2022-04-19 | 4 | Lang Matthew | MYOV | Common Shares | D | 10,4500 | -8 002 | -84 | 276 037 | ||||
| 2022-04-21 | 2022-04-19 | 4 | Merendino Lauren | MYOV | Common Shares | D | 10,4500 | -7 049 | -74 | 174 953 | ||||
| 2022-04-21 | 2022-04-19 | 4 | Marek David C | MYOV | Common Shares | D | 10,4500 | -24 594 | -257 | 447 956 | ||||
| 2022-04-19 | 2022-04-15 | 4 | Mehra Uneek | MYOV | Common Shares | D | 111 111 | 214 180 | ||||||
| 2022-04-19 | 2022-04-15 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 103 703 | 264 761 | ||||||
| 2022-04-19 | 2022-04-15 | 4 | Merendino Lauren | MYOV | Common Shares | D | 103 703 | 182 002 | ||||||
| 2022-04-19 | 2022-04-15 | 4 | Lang Matthew | MYOV | Common Shares | D | 111 111 | 284 039 | ||||||
| 2022-04-19 | 2022-04-15 | 4 | Marek David C | MYOV | Stock Option (Right to Buy) | D | 11,33 | 204 808 | 204 808 | |||||
| 2022-04-19 | 2022-04-15 | 4 | Marek David C | MYOV | Common Shares | D | 134 567 | 472 550 | ||||||
| 2022-04-07 | 2022-04-05 | 4 | Lang Matthew | MYOV | Common Shares | D | 13,7800 | -2 436 | -34 | 172 928 | ||||
| 2022-04-07 | 2022-04-05 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 13,7800 | -1 922 | -26 | 161 058 | ||||
| 2022-03-03 | 2022-03-01 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 13,3500 | -1 362 | -18 | 162 980 | ||||
| 2022-01-21 | 2022-01-19 | 4 | Marek David C | MYOV | Common Shares | D | 14,6800 | -19 882 | -292 | 337 983 | ||||
| 2022-01-06 | 2022-01-04 | 4 | Lang Matthew | MYOV | Common Shares | D | 16,2700 | -4 475 | -73 | 175 364 | ||||
| 2022-01-06 | 2022-01-04 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 16,2700 | -2 271 | -37 | 164 342 | ||||
| 2021-12-01 | 2021-11-29 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 19,3000 | -1 978 | -38 | 166 613 | ||||
| 2021-11-09 | 2021-11-05 | 4 | Curran Terrie | MYOV | Stock Option (Right to Buy) | D | 22,71 | 21 096 | 21 096 | |||||
| 2021-11-09 | 2021-11-05 | 4 | GUINAN MARK | MYOV | Stock Option (Right to Buy) | D | 22,71 | 21 096 | 21 096 | |||||
| 2021-11-09 | 2021-11-05 | 4 | Gulfo Adele M. | MYOV | Stock Option (Right to Buy) | D | 22,71 | 21 096 | 21 096 | |||||
| 2021-11-09 | 2021-11-05 | 4 | POTTER MYRTLE S | MYOV | Stock Option (Right to Buy) | D | 22,71 | 21 096 | 21 096 | |||||
| 2021-11-09 | 2021-11-05 | 4 | Valente Nancy | MYOV | Stock Option (Right to Buy) | D | 22,71 | 36 892 | 36 892 | |||||
| 2021-11-09 | 3 | Valente Nancy | MYOV | Common Shares | D | 0 | ||||||||
| 2021-11-05 | 2021-11-04 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option | D | 7,78 | -3 100 | 155 300 | |||||
| 2021-11-05 | 2021-11-04 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 24,0200 | -3 100 | -74 | 168 591 | ||||
| 2021-11-05 | 2021-11-04 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 7,7800 | 3 100 | 24 | 171 691 | ||||
| 2021-11-05 | 2021-11-03 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -700 | 158 400 | |||||
| 2021-11-05 | 2021-11-03 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 24,0000 | -700 | -17 | 168 591 | ||||
| 2021-11-05 | 2021-11-03 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 7,7800 | 700 | 5 | 169 291 | ||||
| 2021-10-07 | 2021-10-05 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 21,6200 | -2 738 | -59 | 168 591 | ||||
| 2021-10-07 | 2021-10-05 | 4 | Lang Matthew | MYOV | Common Shares | D | 21,6200 | -6 671 | -144 | 179 839 | ||||
| 2021-09-30 | 2021-09-28 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 22,8458 | 20 677 | 472 | 50 041 181 | ||||
| 2021-09-29 | 2021-09-27 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -7 000 | 159 100 | |||||
| 2021-09-29 | 2021-09-27 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 24,3200 | -7 000 | -170 | 171 329 | ||||
| 2021-09-29 | 2021-09-27 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 7,7800 | 7 000 | 54 | 178 329 | ||||
| 2021-09-28 | 2021-09-27 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 24,8594 | 2 232 | 55 | 50 020 504 | ||||
| 2021-09-28 | 2021-09-27 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 24,1851 | 45 768 | 1 107 | 50 018 272 | ||||
| 2021-09-28 | 2021-09-24 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 23,4041 | 36 000 | 843 | 49 972 504 | ||||
| 2021-09-24 | 2021-09-23 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 23,4885 | 5 311 | 125 | 49 936 504 | ||||
| 2021-09-24 | 2021-09-23 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 23,0147 | 49 467 | 1 138 | 49 931 193 | ||||
| 2021-09-24 | 2021-09-22 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 21,9597 | 84 018 | 1 845 | 49 881 726 | ||||
| 2021-09-22 | 2021-09-21 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 22,4756 | 43 000 | 966 | 49 797 708 | ||||
| 2021-09-22 | 2021-09-20 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 22,0957 | 38 273 | 846 | 49 754 708 | ||||
| 2021-09-20 | 2021-09-17 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 22,7918 | 37 913 | 864 | 49 716 435 | ||||
| 2021-09-20 | 2021-09-16 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 21,7510 | 50 000 | 1 088 | 49 678 522 | ||||
| 2021-09-17 | 2021-09-15 | 4 | Mehra Uneek | MYOV | Stock Options (Right to Buy) | D | 21,83 | 165 192 | 165 192 | |||||
| 2021-09-17 | 2021-09-15 | 4 | Mehra Uneek | MYOV | Common Shares | D | 103 069 | 103 069 | ||||||
| 2021-09-16 | 2021-09-15 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 21,9831 | 89 864 | 1 975 | 49 628 522 | ||||
| 2021-09-16 | 2021-09-14 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 22,7555 | 6 172 | 140 | 49 538 658 | ||||
| 2021-09-16 | 2021-09-14 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 22,0372 | 65 128 | 1 435 | 49 532 486 | ||||
| 2021-09-14 | 2021-09-13 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 23,9107 | 30 028 | 718 | 49 467 358 | ||||
| 2021-09-14 | 2021-09-13 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 23,0867 | 53 150 | 1 227 | 49 437 330 | ||||
| 2021-09-14 | 2021-09-10 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 25,1130 | 30 000 | 753 | 49 384 180 | ||||
| 2021-09-13 | 2021-09-09 | 4 | Curran Terrie | MYOV | Stock Option (Right to Buy) | D | 7,65 | -4 850 | 5 250 | |||||
| 2021-09-13 | 2021-09-09 | 4 | Curran Terrie | MYOV | Common Shares | D | 25,5800 | -4 850 | -124 | 0 | ||||
| 2021-09-13 | 2021-09-09 | 4 | Curran Terrie | MYOV | Common Shares | D | 7,6500 | 4 850 | 37 | 4 850 | ||||
| 2021-09-10 | 2021-09-09 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 25,5175 | 37 000 | 944 | 49 354 180 | ||||
| 2021-09-10 | 2021-09-08 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 25,7357 | 21 902 | 564 | 49 317 180 | ||||
| 2021-09-09 | 3 | Mehra Uneek | MYOV | Common Shares | D | 0 | ||||||||
| 2021-09-08 | 2021-09-07 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 27,1218 | 4 913 | 133 | 49 295 278 | ||||
| 2021-09-08 | 2021-09-07 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 26,0784 | 28 287 | 738 | 49 290 365 | ||||
| 2021-09-08 | 2021-09-03 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 27,2931 | 1 378 | 38 | 49 262 078 | ||||
| 2021-09-08 | 2021-09-03 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 26,7381 | 29 822 | 797 | 49 260 700 | ||||
| 2021-09-03 | 2021-09-02 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 26,9547 | 5 848 | 158 | 49 230 878 | ||||
| 2021-09-03 | 2021-09-02 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 26,4628 | 35 045 | 927 | 49 225 030 | ||||
| 2021-09-03 | 2021-09-02 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 25,2543 | 22 209 | 561 | 49 189 985 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 24,8257 | 40 000 | 993 | 49 167 776 | ||||
| 2021-09-03 | 2021-09-02 | 4 | Curran Terrie | MYOV | Stock Option (Right to Buy) | D | 7,65 | -37 135 | 10 100 | |||||
| 2021-09-03 | 2021-09-02 | 4 | Curran Terrie | MYOV | Common Shares | D | 25,0300 | -37 135 | -929 | 0 | ||||
| 2021-09-03 | 2021-09-02 | 4 | Curran Terrie | MYOV | Common Shares | D | 7,6500 | 37 135 | 284 | 37 135 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Curran Terrie | MYOV | Stock Option (Right to Buy) | D | 7,65 | -11 373 | 47 235 | |||||
| 2021-09-03 | 2021-09-01 | 4 | Curran Terrie | MYOV | Common Shares | D | 25,0000 | -11 373 | -284 | 0 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Curran Terrie | MYOV | Common Shares | D | 7,6500 | 11 373 | 87 | 11 373 | ||||
| 2021-09-01 | 2021-08-31 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 24,2791 | 39 000 | 947 | 49 127 776 | ||||
| 2021-09-01 | 2021-08-30 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 23,9157 | 70 000 | 1 674 | 49 088 776 | ||||
| 2021-08-31 | 2021-08-30 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -21 000 | 166 100 | |||||
| 2021-08-31 | 2021-08-30 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 24,0500 | -21 000 | -505 | 171 329 | ||||
| 2021-08-31 | 2021-08-30 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 7,7800 | 21 000 | 163 | 192 329 | ||||
| 2021-08-31 | 2021-08-27 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 22,6900 | -1 978 | -45 | 171 329 | ||||
| 2021-08-30 | 2021-08-27 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 23,1722 | 37 038 | 858 | 49 018 776 | ||||
| 2021-08-30 | 2021-08-26 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 22,6728 | 40 000 | 907 | 48 981 738 | ||||
| 2021-08-26 | 2021-08-25 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 22,4375 | 28 709 | 644 | 48 941 738 | ||||
| 2021-08-26 | 2021-08-24 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 22,3700 | 34 299 | 767 | 48 913 029 | ||||
| 2021-08-24 | 2021-08-23 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 22,4522 | 30 390 | 682 | 48 878 730 | ||||
| 2021-08-24 | 2021-08-23 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 22,1261 | 25 057 | 554 | 48 848 340 | ||||
| 2021-08-24 | 2021-08-20 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 20,8602 | 46 478 | 970 | 48 823 283 | ||||
| 2021-08-20 | 2021-08-19 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 21,5084 | 46 792 | 1 006 | 48 776 805 | ||||
| 2021-08-20 | 2021-08-18 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 21,4473 | 17 116 | 367 | 48 730 013 | ||||
| 2021-08-18 | 2021-08-17 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 20,8947 | 23 549 | 492 | 48 712 897 | ||||
| 2021-08-18 | 2021-08-16 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 21,9416 | 5 382 | 118 | 48 689 348 | ||||
| 2021-08-18 | 2021-08-16 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 21,2938 | 42 785 | 911 | 48 683 966 | ||||
| 2021-07-13 | 2021-07-09 | 4 | Lang Matthew | MYOV | Common Shares | D | 21,5200 | -6 954 | -150 | 186 510 | ||||
| 2021-07-09 | 2021-07-07 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 21,7500 | -2 777 | -60 | 173 307 | ||||
| 2021-07-09 | 2021-07-07 | 4 | KARBE FRANK | MYOV | Common Shares | D | 21,7500 | -3 232 | -70 | 212 296 | ||||
| 2021-06-02 | 2021-05-28 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -1 300 | 187 100 | |||||
| 2021-06-02 | 2021-05-28 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 24,0000 | -1 783 | -43 | 176 084 | ||||
| 2021-06-02 | 2021-05-28 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 24,0000 | -1 300 | -31 | 177 867 | ||||
| 2021-06-02 | 2021-05-28 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 7,7800 | 1 300 | 10 | 179 167 | ||||
| 2021-05-28 | 2021-05-26 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -2 867 | 188 400 | |||||
| 2021-05-28 | 2021-05-26 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -9 833 | 63 717 | |||||
| 2021-05-28 | 2021-05-26 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 24,2300 | -12 700 | -308 | 177 867 | ||||
| 2021-05-28 | 2021-05-26 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 7,7800 | 12 700 | 99 | 190 567 | ||||
| 2021-04-19 | 2021-04-15 | 4 | Lang Matthew | MYOV | Stock Option (Right to Buy) | D | 17,88 | 90 310 | 90 310 | |||||
| 2021-04-19 | 2021-04-15 | 4 | Lang Matthew | MYOV | Common Shares | D | 58 461 | 193 464 | ||||||
| 2021-04-19 | 2021-04-15 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 17,88 | 97 534 | 97 534 | |||||
| 2021-04-19 | 2021-04-15 | 4 | KARBE FRANK | MYOV | Common Shares | D | 63 138 | 215 528 | ||||||
| 2021-04-19 | 2021-04-15 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 17,88 | 79 472 | 79 472 | |||||
| 2021-04-19 | 2021-04-15 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 51 446 | 177 867 | ||||||
| 2021-04-19 | 2021-04-15 | 4 | Marek David C | MYOV | Stock Option (Right to Buy) | D | 17,88 | 208 218 | 208 218 | |||||
| 2021-04-19 | 2021-04-15 | 4 | Marek David C | MYOV | Common Shares | D | 134 789 | 357 865 | ||||||
| 2021-04-19 | 2021-04-15 | 4 | Merendino Lauren | MYOV | Stock Option (Right to Buy) | D | 17,88 | 123 300 | 123 300 | |||||
| 2021-04-19 | 2021-04-15 | 4 | Merendino Lauren | MYOV | Common Shares | D | 78 299 | 78 299 | ||||||
| 2021-04-08 | 2021-04-06 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 18,6300 | -8 114 | -151 | 126 421 | ||||
| 2021-04-08 | 2021-04-06 | 4 | Lang Matthew | MYOV | Common Shares | D | 18,6200 | -10 862 | -202 | 135 003 | ||||
| 2021-04-08 | 2021-04-06 | 4 | KARBE FRANK | MYOV | Common Shares | D | 18,6300 | -11 080 | -206 | 152 390 | ||||
| 2021-04-08 | 3 | Merendino Lauren | MYOV | Common Shares | D | 0 | ||||||||
| 2021-03-23 | 2021-03-19 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -7 000 | 73 550 | |||||
| 2021-03-23 | 2021-03-19 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 24,1700 | -7 000 | -169 | 134 535 | ||||
| 2021-03-23 | 2021-03-19 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 7,7800 | 7 000 | 54 | 141 535 | ||||
| 2021-03-17 | 2021-03-15 | 4 | Lang Matthew | MYOV | Stock Option (Right to Buy) | D | 7,78 | -30 000 | 220 000 | |||||
| 2021-03-17 | 2021-03-15 | 4 | Lang Matthew | MYOV | Common Shares | D | 25,0671 | -30 000 | -752 | 145 865 | ||||
| 2021-03-17 | 2021-03-15 | 4 | Lang Matthew | MYOV | Common Shares | D | 7,7800 | 30 000 | 233 | 175 865 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 22,5500 | -1 513 | -34 | 134 535 | ||||
| 2021-02-18 | 2021-02-16 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 5,11 | -750 | 181 744 | |||||
| 2021-02-18 | 2021-02-16 | 4 | KARBE FRANK | MYOV | Common Shares | D | 21,4000 | -750 | -16 | 163 470 | ||||
| 2021-02-18 | 2021-02-16 | 4 | KARBE FRANK | MYOV | Common Shares | D | 5,1100 | 750 | 4 | 164 220 | ||||
| 2021-02-01 | 2021-01-28 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 5,11 | -300 | 182 494 | |||||
| 2021-02-01 | 2021-01-28 | 4 | KARBE FRANK | MYOV | Common Shares | D | 24,0000 | -300 | -7 | 163 470 | ||||
| 2021-02-01 | 2021-01-28 | 4 | KARBE FRANK | MYOV | Common Shares | D | 5,1100 | 300 | 2 | 163 770 | ||||
| 2021-01-20 | 2021-01-15 | 4 | Marek David C | MYOV | Stock Option (Right to Buy) | D | 20,54 | 306 427 | 306 427 | |||||
| 2021-01-20 | 2021-01-15 | 4 | Marek David C | MYOV | Common Shares | D | 223 076 | 223 076 | ||||||
| 2021-01-20 | 2021-01-15 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 5,11 | -750 | 182 794 | |||||
| 2021-01-20 | 2021-01-15 | 4 | KARBE FRANK | MYOV | Common Shares | D | 21,5000 | -750 | -16 | 163 470 | ||||
| 2021-01-20 | 2021-01-15 | 4 | KARBE FRANK | MYOV | Common Shares | D | 5,1100 | 750 | 4 | 164 220 | ||||
| 2021-01-12 | 3 | Marek David C | MYOV | Common Shares | D | 0 | ||||||||
| 2020-12-30 | 2020-12-28 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 5,11 | -11 800 | 183 544 | |||||
| 2020-12-30 | 2020-12-28 | 4 | KARBE FRANK | MYOV | Common Shares | D | 30,0000 | -11 800 | -354 | 163 470 | ||||
| 2020-12-30 | 2020-12-28 | 4 | KARBE FRANK | MYOV | Common Shares | D | 5,1100 | 11 800 | 60 | 175 270 | ||||
| 2020-12-22 | 2020-12-18 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -2 000 | 191 267 | |||||
| 2020-12-22 | 2020-12-18 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 26,0000 | -2 000 | -52 | 136 048 | ||||
| 2020-12-22 | 2020-12-18 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 7,7800 | 2 000 | 16 | 138 048 | ||||
| 2020-12-22 | 2020-12-18 | 4 | Lang Matthew | MYOV | Stock Option (Right to Buy) | D | 7,78 | -10 000 | 250 000 | |||||
| 2020-12-22 | 2020-12-18 | 4 | Lang Matthew | MYOV | Common Shares | D | 26,2367 | -300 | -8 | 145 865 | ||||
| 2020-12-22 | 2020-12-18 | 4 | Lang Matthew | MYOV | Common Shares | D | 25,3797 | -9 700 | -246 | 146 165 | ||||
| 2020-12-22 | 2020-12-18 | 4 | Lang Matthew | MYOV | Common Shares | D | 7,7800 | 10 000 | 78 | 155 865 | ||||
| 2020-12-17 | 2020-12-15 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -7 000 | 193 267 | |||||
| 2020-12-17 | 2020-12-15 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 24,1815 | -3 467 | -84 | 136 048 | ||||
| 2020-12-17 | 2020-12-15 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 23,6595 | -3 533 | -84 | 139 515 | ||||
| 2020-12-17 | 2020-12-15 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 7,7800 | 7 000 | 54 | 143 048 | ||||
| 2020-12-17 | 2020-12-15 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 5,11 | -1 050 | 195 344 | |||||
| 2020-12-17 | 2020-12-15 | 4 | KARBE FRANK | MYOV | Common Stock | D | 24,4515 | -670 | -16 | 163 470 | ||||
| 2020-12-17 | 2020-12-15 | 4 | KARBE FRANK | MYOV | Common Shares | D | 23,6321 | -380 | -9 | 164 140 | ||||
| 2020-12-17 | 2020-12-15 | 4 | KARBE FRANK | MYOV | Common Shares | D | 5,1100 | 1 050 | 5 | 164 520 | ||||
| 2020-12-14 | 2020-12-10 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -10 000 | 200 267 | |||||
| 2020-12-14 | 2020-12-10 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 26,0362 | -10 000 | -260 | 136 048 | ||||
| 2020-12-14 | 2020-12-10 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 7,7800 | 10 000 | 78 | 146 048 | ||||
| 2020-12-11 | 2020-12-10 | 4 | Lang Matthew | MYOV | Stock Option (Right to Buy) | D | 7,78 | -19 400 | 260 000 | |||||
| 2020-12-11 | 2020-12-10 | 4 | Lang Matthew | MYOV | Common Shares | D | 25,1950 | -19 400 | -489 | 145 865 | ||||
| 2020-12-11 | 2020-12-10 | 4 | Lang Matthew | MYOV | Common Shares | D | 7,7800 | 19 400 | 151 | 165 265 | ||||
| 2020-12-11 | 2020-12-09 | 4 | Lang Matthew | MYOV | Stock Option (Right to Buy) | D | 7,78 | -600 | 279 400 | |||||
| 2020-12-11 | 2020-12-09 | 4 | Lang Matthew | MYOV | Common Shares | D | 25,0817 | -600 | -15 | 145 865 | ||||
| 2020-12-11 | 2020-12-09 | 4 | Lang Matthew | MYOV | Common Shares | D | 7,7800 | 600 | 5 | 146 465 | ||||
| 2020-12-02 | 2020-11-30 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 23,6500 | -1 978 | -47 | 136 048 | ||||
| 2020-12-02 | 2020-11-30 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 5,11 | -1 500 | 196 394 | |||||
| 2020-12-02 | 2020-11-30 | 4 | KARBE FRANK | MYOV | Common Shares | D | 24,0000 | -1 500 | -36 | 163 470 | ||||
| 2020-12-02 | 2020-11-30 | 4 | KARBE FRANK | MYOV | Common Shares | D | 5,1100 | 1 500 | 8 | 164 970 | ||||
| 2020-11-19 | 2020-11-17 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -7 000 | 210 267 | |||||
| 2020-11-19 | 2020-11-17 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 20,0000 | -7 000 | -140 | 138 026 | ||||
| 2020-11-19 | 2020-11-17 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 7,7800 | 7 000 | 54 | 145 026 | ||||
| 2020-11-19 | 2020-11-17 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 5,11 | -750 | 197 894 | |||||
| 2020-11-19 | 2020-11-17 | 4 | KARBE FRANK | MYOV | Common Shares | D | 20,0000 | -750 | -15 | 163 470 | ||||
| 2020-11-19 | 2020-11-17 | 4 | KARBE FRANK | MYOV | Common Shares | D | 5,1100 | 750 | 4 | 164 220 | ||||
| 2020-11-17 | 2020-11-13 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 5,11 | -750 | 198 644 | |||||
| 2020-11-17 | 2020-11-13 | 4 | KARBE FRANK | MYOV | Common Shares | D | 20,0000 | -750 | -15 | 163 470 | ||||
| 2020-11-17 | 2020-11-13 | 4 | KARBE FRANK | MYOV | Common Shares | D | 5,1100 | 750 | 4 | 164 220 | ||||
| 2020-11-17 | 2020-11-13 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -7 000 | 217 267 | |||||
| 2020-11-17 | 2020-11-13 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 20,0000 | -7 000 | -140 | 138 026 | ||||
| 2020-11-17 | 2020-11-13 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 7,7800 | 7 000 | 54 | 145 026 | ||||
| 2020-09-17 | 2020-09-15 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 5,11 | -750 | 199 394 | |||||
| 2020-09-17 | 2020-09-15 | 4 | KARBE FRANK | MYOV | Common Shares | D | 21,7300 | -750 | -16 | 163 470 | ||||
| 2020-09-17 | 2020-09-15 | 4 | KARBE FRANK | MYOV | Common Shares | D | 5,1100 | 750 | 4 | 164 220 | ||||
| 2020-09-17 | 2020-09-15 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -7 000 | 224 267 | |||||
| 2020-09-17 | 2020-09-15 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 22,4500 | -100 | -2 | 138 026 | ||||
| 2020-09-17 | 2020-09-15 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 21,7600 | -6 900 | -150 | 138 126 | ||||
| 2020-09-17 | 2020-09-15 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 7,7800 | 7 000 | 54 | 145 026 | ||||
| 2020-09-17 | 2020-09-15 | 4 | Gulfo Adele M. | MYOV | Stock Option (Right to Buy) | D | 21,47 | 21 603 | 21 603 | |||||
| 2020-09-17 | 2020-09-15 | 4 | GUINAN MARK | MYOV | Stock Option (Right to Buy) | D | 21,47 | 21 603 | 21 603 | |||||
| 2020-09-17 | 2020-09-15 | 4 | Curran Terrie | MYOV | Stock Option (Right to Buy) | D | 21,47 | 21 603 | 21 603 | |||||
| 2020-09-17 | 2020-09-15 | 4 | POTTER MYRTLE S | MYOV | Stock Option (Right to Buy) | D | 21,47 | 21 603 | 21 603 | |||||
| 2020-09-17 | 2020-09-15 | 4 | Sebelius Kathleen | MYOV | Stock Option (Right to Buy) | D | 21,47 | 21 603 | 21 603 | |||||
| 2020-09-02 | 2020-08-31 | 4 | Lang Matthew | MYOV | Stock Option (Right to Buy) | D | 7,78 | -26 700 | 280 000 | |||||
| 2020-09-02 | 2020-08-31 | 4 | Lang Matthew | MYOV | Common Shares | D | 20,0480 | -26 700 | -535 | 145 865 | ||||
| 2020-09-02 | 2020-08-31 | 4 | Lang Matthew | MYOV | Common Shares | D | 7,7800 | 26 700 | 208 | 172 565 | ||||
| 2020-09-02 | 2020-08-31 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -11 307 | 231 267 | |||||
| 2020-09-02 | 2020-08-31 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 20,0050 | -11 307 | -226 | 138 026 | ||||
| 2020-09-02 | 2020-08-31 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 7,7800 | 11 307 | 88 | 149 333 | ||||
| 2020-09-01 | 2020-08-31 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 5,11 | -21 150 | 200 144 | |||||
| 2020-09-01 | 2020-08-31 | 4 | KARBE FRANK | MYOV | Common Shares | D | 20,0130 | -21 150 | -423 | 163 470 | ||||
| 2020-09-01 | 2020-08-31 | 4 | KARBE FRANK | MYOV | Common Shares | D | 5,1100 | 21 150 | 108 | 184 620 | ||||
| 2020-09-01 | 2020-08-28 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 5,11 | -3 650 | 221 294 | |||||
| 2020-09-01 | 2020-08-28 | 4 | KARBE FRANK | MYOV | Common Shares | D | 20,0400 | -3 650 | -73 | 163 470 | ||||
| 2020-09-01 | 2020-08-28 | 4 | KARBE FRANK | MYOV | Common Shares | D | 5,1100 | 3 650 | 19 | 167 120 | ||||
| 2020-08-31 | 2020-08-28 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -1 791 | 242 574 | |||||
| 2020-08-31 | 2020-08-28 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -267 | 65 863 | |||||
| 2020-08-31 | 2020-08-28 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 20,0100 | -2 058 | -41 | 138 026 | ||||
| 2020-08-31 | 2020-08-28 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 7,7800 | 2 058 | 16 | 140 084 | ||||
| 2020-08-31 | 2020-08-27 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 18,8000 | -7 089 | -133 | 138 026 | ||||
| 2020-08-28 | 2020-08-28 | 4 | Lang Matthew | MYOV | Stock Option (Right to Buy) | D | 7,78 | -2 600 | 306 700 | |||||
| 2020-08-28 | 2020-08-28 | 4 | Lang Matthew | MYOV | Common Shares | D | 20,0200 | -2 600 | -52 | 145 865 | ||||
| 2020-08-28 | 2020-08-28 | 4 | Lang Matthew | MYOV | Common Shares | D | 7,7800 | 2 600 | 20 | 148 465 | ||||
| 2020-08-28 | 2020-08-26 | 4 | Lang Matthew | MYOV | Stock Option (Right to Buy) | D | 7,78 | -100 | 309 300 | |||||
| 2020-08-28 | 2020-08-26 | 4 | Lang Matthew | MYOV | Common Shares | D | 20,0000 | -100 | -2 | 145 865 | ||||
| 2020-08-28 | 2020-08-26 | 4 | Lang Matthew | MYOV | Common Shares | D | 7,7800 | 100 | 1 | 145 965 | ||||
| 2020-08-21 | 2020-08-19 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 5,11 | -700 | 224 944 | |||||
| 2020-08-21 | 2020-08-19 | 4 | KARBE FRANK | MYOV | Common Shares | D | 20,0000 | -700 | -14 | 163 470 | ||||
| 2020-08-21 | 2020-08-19 | 4 | KARBE FRANK | MYOV | Common Shares | D | 5,1100 | 700 | 4 | 164 170 | ||||
| 2020-08-21 | 2020-08-19 | 4 | Lang Matthew | MYOV | Stock Option (Right to Buy) | D | 7,78 | -600 | 309 400 | |||||
| 2020-08-21 | 2020-08-19 | 4 | Lang Matthew | MYOV | Common Shares | D | 20,0000 | -600 | -12 | 145 865 | ||||
| 2020-08-21 | 2020-08-19 | 4 | Lang Matthew | MYOV | Common Shares | D | 7,7800 | 600 | 5 | 146 465 | ||||
| 2020-08-21 | 2020-08-19 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -635 | 244 365 | |||||
| 2020-08-21 | 2020-08-19 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 20,0000 | -635 | -13 | 145 115 | ||||
| 2020-08-21 | 2020-08-19 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 7,7800 | 635 | 5 | 145 750 | ||||
| 2020-06-26 | 2020-06-24 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -6 500 | 80 550 | |||||
| 2020-06-26 | 2020-06-24 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -10 946 | 245 000 | |||||
| 2020-06-26 | 2020-06-24 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Stock | D | 20,0000 | -17 446 | -349 | 145 115 | ||||
| 2020-06-26 | 2020-06-24 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Stock | D | 7,7800 | 6 500 | 51 | 162 561 | ||||
| 2020-06-26 | 2020-06-24 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Stock | D | 7,7800 | 10 946 | 85 | 156 061 | ||||
| 2020-06-24 | 2020-06-23 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | -4 054 | 255 946 | |||||
| 2020-06-24 | 2020-06-23 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Stock | D | 20,0000 | -4 054 | -81 | 145 115 | ||||
| 2020-06-24 | 2020-06-23 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Stock | D | 7,7800 | 4 054 | 32 | 149 169 | ||||
| 2020-05-21 | 2020-05-20 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 12,5831 | 37 897 | 477 | 48 641 181 | ||||
| 2020-05-21 | 2020-05-19 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 12,1010 | 50 000 | 605 | 48 603 284 | ||||
| 2020-05-19 | 2020-05-18 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 12,3607 | 35 000 | 433 | 48 553 284 | ||||
| 2020-05-19 | 2020-05-15 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 12,1249 | 49 812 | 604 | 48 518 284 | ||||
| 2020-05-15 | 2020-05-14 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 12,0152 | 50 000 | 601 | 48 468 472 | ||||
| 2020-05-15 | 2020-05-13 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 12,3791 | 41 331 | 512 | 48 418 472 | ||||
| 2020-05-13 | 2020-05-12 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 13,5146 | 24 448 | 330 | 48 377 141 | ||||
| 2020-05-13 | 2020-05-11 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 12,7824 | 35 000 | 447 | 48 352 693 | ||||
| 2020-05-11 | 2020-05-06 | 4/A | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 12,2415 | 50 000 | 612 | 48 247 693 | ||||
| 2020-05-11 | 2020-05-08 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 12,8307 | 35 000 | 449 | 48 317 693 | ||||
| 2020-05-11 | 2020-05-07 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 12,6325 | 35 000 | 442 | 48 282 693 | ||||
| 2020-05-07 | 2020-05-05 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 12,2415 | 50 000 | 612 | 48 247 693 | ||||
| 2020-05-07 | 2020-05-05 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 11,6893 | 50 000 | 584 | 48 197 693 | ||||
| 2020-05-05 | 2020-05-04 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 11,4974 | 50 000 | 575 | 48 147 693 | ||||
| 2020-05-05 | 2020-05-01 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 11,3836 | 50 000 | 569 | 48 097 693 | ||||
| 2020-05-01 | 2020-04-30 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 12,0765 | 50 000 | 604 | 48 047 693 | ||||
| 2020-05-01 | 2020-04-29 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 11,9179 | 50 000 | 596 | 47 997 693 | ||||
| 2020-04-29 | 2020-04-28 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 12,0544 | 50 000 | 603 | 47 947 693 | ||||
| 2020-04-29 | 2020-04-27 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 12,1794 | 40 503 | 493 | 47 897 693 | ||||
| 2020-04-27 | 2020-04-24 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 12,1465 | 43 086 | 523 | 47 857 190 | ||||
| 2020-04-27 | 2020-04-23 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 12,3458 | 35 000 | 432 | 47 814 104 | ||||
| 2020-04-23 | 2020-04-22 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 11,9346 | 50 000 | 597 | 47 779 104 | ||||
| 2020-04-23 | 2020-04-21 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 11,5765 | 50 200 | 581 | 47 729 104 | ||||
| 2020-04-21 | 2020-04-20 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 11,8176 | 50 300 | 594 | 47 678 904 | ||||
| 2020-04-21 | 2020-04-17 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 10,7648 | 70 000 | 754 | 47 628 604 | ||||
| 2020-04-17 | 2020-04-16 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 10,6382 | 70 000 | 745 | 47 558 604 | ||||
| 2020-04-17 | 2020-04-15 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 10,4814 | 70 000 | 734 | 47 488 604 | ||||
| 2020-04-15 | 2020-04-14 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 11,0015 | 70 000 | 770 | 47 418 604 | ||||
| 2020-04-15 | 2020-04-13 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 9,8078 | 70 000 | 687 | 47 348 604 | ||||
| 2020-04-13 | 2020-04-09 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 9,3667 | 70 000 | 656 | 47 278 604 | ||||
| 2020-04-09 | 2020-04-08 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 8,5277 | 70 000 | 597 | 47 208 604 | ||||
| 2020-04-09 | 2020-04-07 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 8,2052 | 70 000 | 574 | 47 138 604 | ||||
| 2020-04-07 | 2020-04-03 | 4 | Seely Lynn | MYOV | Employee Stock Option (Right to Buy) | D | 8,08 | 302 693 | 302 693 | |||||
| 2020-04-07 | 2020-04-03 | 4 | Seely Lynn | MYOV | Common Shares | D | 197 659 | 1 043 824 | ||||||
| 2020-04-07 | 2020-04-03 | 4 | Arjona Ferreira Juan Camilo | MYOV | Employee Stock Option (Right to Buy) | D | 8,08 | 134 464 | 134 464 | |||||
| 2020-04-07 | 2020-04-03 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 87 805 | 145 115 | ||||||
| 2020-04-07 | 2020-04-03 | 4 | KARBE FRANK | MYOV | Employee Stock Option (Right to Buy) | D | 8,08 | 183 991 | 183 991 | |||||
| 2020-04-07 | 2020-04-03 | 4 | KARBE FRANK | MYOV | Common Shares | D | 120 146 | 163 470 | ||||||
| 2020-04-07 | 2020-04-03 | 4 | Lang Matthew | MYOV | Employee Stock Option (Right to Buy) | D | 8,08 | 170 396 | 170 396 | |||||
| 2020-04-07 | 2020-04-03 | 4 | Lang Matthew | MYOV | Common Shares | D | 111 268 | 145 865 | ||||||
| 2020-04-07 | 2020-04-03 | 4 | Sablich Kim | MYOV | Employee Stock Option (Right to Buy) | D | 8,08 | 134 464 | 134 464 | |||||
| 2020-04-07 | 2020-04-03 | 4 | Sablich Kim | MYOV | Common Shares | D | 87 805 | 146 710 | ||||||
| 2020-04-07 | 2020-04-06 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 8,4360 | 70 000 | 591 | 47 068 604 | ||||
| 2020-04-07 | 2020-04-03 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 7,9275 | 70 000 | 555 | 46 998 604 | ||||
| 2020-04-03 | 2020-04-02 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 7,7298 | 70 000 | 541 | 46 928 604 | ||||
| 2020-04-03 | 2020-04-01 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 7,4614 | 70 000 | 522 | 46 858 604 | ||||
| 2020-04-01 | 2020-03-31 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 7,9712 | 70 000 | 558 | 46 788 604 | ||||
| 2020-04-01 | 2020-03-30 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 7,6538 | 70 000 | 536 | 46 718 604 | ||||
| 2020-03-30 | 2020-03-27 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 7,9750 | 70 000 | 558 | 46 648 604 | ||||
| 2020-03-30 | 2020-03-26 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 7,9401 | 70 000 | 556 | 46 578 604 | ||||
| 2020-03-26 | 2020-03-25 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 7,6031 | 108 100 | 822 | 46 508 604 | ||||
| 2020-03-26 | 2020-03-24 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 7,6731 | 211 200 | 1 621 | 46 400 504 | ||||
| 2020-03-24 | 2020-03-23 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 7,6796 | 211 200 | 1 622 | 46 189 304 | ||||
| 2020-03-24 | 2020-03-20 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 7,5952 | 193 900 | 1 473 | 45 978 104 | ||||
| 2020-03-20 | 2020-03-19 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 7,6790 | 193 900 | 1 489 | 45 784 204 | ||||
| 2020-03-20 | 2020-03-18 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 7,4004 | 193 900 | 1 435 | 45 590 304 | ||||
| 2020-03-19 | 2020-03-18 | 4 | Sablich Kim | MYOV | Common Stock | D | 6,9300 | -15 | -0 | 58 905 | ||||
| 2020-03-19 | 2020-03-18 | 4 | Sablich Kim | MYOV | Common Stock | D | 7,3800 | -770 | -6 | 58 920 | ||||
| 2020-03-18 | 2020-03-17 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 7,3953 | 193 900 | 1 434 | 45 396 404 | ||||
| 2020-03-18 | 2020-03-16 | 4 | Sumitomo Chemical Co., Ltd. | MYOV | Common Stock | I | 7,2512 | 193 900 | 1 406 | 45 202 504 | ||||
| 2020-02-24 | 2020-02-24 | 4 | Gulfo Adele M. | MYOV | Stock Option (Right to Buy) | D | 11,17 | 45 000 | 45 000 | |||||
| 2020-01-16 | 2020-01-15 | 4 | Sablich Kim | MYOV | Common Stock | D | 14,0400 | -4 840 | -68 | 59 690 | ||||
| 2020-01-03 | 3 | Sumitovant Biopharma Ltd. | MYOV | Common Stock | I | 90 017 208 | ||||||||
| 2020-01-03 | 3 | Sumitovant Biopharma Ltd. | MYOV | Common Stock | I | 90 017 208 | ||||||||
| 2020-01-03 | 3 | Sumitovant Biopharma Ltd. | MYOV | Common Stock | I | 90 017 208 | ||||||||
| 2020-01-03 | 3 | Sumitovant Biopharma Ltd. | MYOV | Common Stock | I | 90 017 208 | ||||||||
| 2020-01-03 | 3 | Sumitovant Biopharma Ltd. | MYOV | Common Stock | I | 90 017 208 | ||||||||
| 2019-12-31 | 2019-12-27 | 4 | Roivant Sciences Ltd. | MYOV | Common Shares, par value $0.000017727 per share | I | -45 008 604 | 0 | ||||||
| 2019-12-30 | 2019-12-30 | 4 | KARBE FRANK | MYOV | Common Stock | D | 15,5500 | -19 701 | -306 | 43 324 | ||||
| 2019-12-30 | 2019-12-30 | 4 | Lang Matthew | MYOV | Common Stock | D | 15,5500 | -19 018 | -296 | 34 597 | ||||
| 2019-12-30 | 3 | Gulfo Adele M. | MYOV | Common Shares | D | 0 | ||||||||
| 2019-12-30 | 3 | Nomura Hiroshi | MYOV | Common Shares | D | 0 | ||||||||
| 2019-12-19 | 2019-12-18 | 4 | Sablich Kim | MYOV | Common Stock | D | 16,2200 | -2 585 | -42 | 64 530 | ||||
| 2019-12-18 | 2019-12-17 | 4 | Roivant Sciences Ltd. | MYOV | Common Shares, par value $0.000017727 per share | D | 15,9400 | 75 000 | 1 196 | 45 008 604 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Roivant Sciences Ltd. | MYOV | Common Shares, par value $0.000017727 per share | D | 15,6800 | 38 459 | 603 | 44 933 604 | ||||
| 2019-12-18 | 2019-12-16 | 4 | Roivant Sciences Ltd. | MYOV | Common Shares, par value $0.000017727 per share | D | 14,9700 | 131 541 | 1 969 | 44 895 145 | ||||
| 2019-12-04 | 2019-12-04 | 4 | Roivant Sciences Ltd. | MYOV | Common Shares, par value $0.000017727 per share | D | 17,5600 | 2 529 | 44 | 44 763 604 | ||||
| 2019-12-04 | 2019-12-04 | 4 | Roivant Sciences Ltd. | MYOV | Common Shares, par value $0.000017727 per share | D | 17,0400 | 72 471 | 1 235 | 44 761 075 | ||||
| 2019-12-04 | 2019-12-02 | 4 | Roivant Sciences Ltd. | MYOV | Common Shares, par value $0.000017727 per share | D | 18,8500 | 65 525 | 1 235 | 44 688 604 | ||||
| 2019-12-04 | 2019-12-02 | 4 | Roivant Sciences Ltd. | MYOV | Common Shares, par value $0.000017727 per share | D | 18,2100 | 113 668 | 2 070 | 44 623 079 | ||||
| 2019-11-27 | 2019-11-25 | 4 | Roivant Sciences Ltd. | MYOV | Common Shares, par value $0.000017727 per share | D | 15,0000 | 3 500 000 | 52 500 | 44 509 411 | ||||
| 2019-11-22 | 2019-11-21 | 4 | Roivant Sciences Ltd. | MYOV | Common Shares, par value $0.000017727 per share | D | 12,3800 | 18 293 | 226 | 41 009 411 | ||||
| 2019-11-22 | 2019-11-21 | 4 | Roivant Sciences Ltd. | MYOV | Common Shares, par value $0.000017727 per share | D | 11,8000 | 103 613 | 1 223 | 40 991 118 | ||||
| 2019-11-22 | 2019-11-20 | 4 | Roivant Sciences Ltd. | MYOV | Common Shares, par value $0.000017727 per share | D | 12,9000 | 121 906 | 1 573 | 40 887 505 | ||||
| 2019-08-27 | 2019-08-26 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | 66 130 | 66 130 | |||||
| 2019-08-27 | 2019-08-26 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 24,44 | -66 130 | 0 | |||||
| 2019-08-27 | 2019-08-26 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | 87 050 | 87 050 | |||||
| 2019-08-27 | 2019-08-26 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 21,87 | -87 050 | 0 | |||||
| 2019-08-27 | 2019-08-26 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 7,78 | 260 000 | 260 000 | |||||
| 2019-08-27 | 2019-08-26 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 10,60 | -260 000 | 0 | |||||
| 2019-08-27 | 2019-08-26 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 47 570 | 57 310 | ||||||
| 2019-08-27 | 2019-08-26 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 7,78 | 132 270 | 132 270 | |||||
| 2019-08-27 | 2019-08-26 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 24,44 | -132 270 | 0 | |||||
| 2019-08-27 | 2019-08-26 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 7,78 | 114 690 | 114 690 | |||||
| 2019-08-27 | 2019-08-26 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 21,87 | -114 690 | 0 | |||||
| 2019-08-27 | 2019-08-26 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 7,78 | 200 000 | 200 000 | |||||
| 2019-08-27 | 2019-08-26 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 12,68 | -200 000 | 0 | |||||
| 2019-08-27 | 2019-08-26 | 4 | KARBE FRANK | MYOV | Common Shares | D | 55 025 | 63 025 | ||||||
| 2019-08-27 | 2019-08-26 | 4 | Lang Matthew | MYOV | Stock Option (Right to Buy) | D | 7,78 | 152 110 | 152 110 | |||||
| 2019-08-27 | 2019-08-26 | 4 | Lang Matthew | MYOV | Stock Option (Right to Buy) | D | 24,44 | -152 110 | 0 | |||||
| 2019-08-27 | 2019-08-26 | 4 | Lang Matthew | MYOV | Stock Option (Right to Buy) | D | 7,78 | 87 050 | 87 050 | |||||
| 2019-08-27 | 2019-08-26 | 4 | Lang Matthew | MYOV | Stock Option (Right to Buy) | D | 21,87 | -87 050 | 0 | |||||
| 2019-08-27 | 2019-08-26 | 4 | Lang Matthew | MYOV | Stock Option (Right to Buy) | D | 7,78 | 310 000 | 310 000 | |||||
| 2019-08-27 | 2019-08-26 | 4 | Lang Matthew | MYOV | Stock Option (Right to Buy) | D | 11,30 | -310 000 | 0 | |||||
| 2019-08-27 | 2019-08-26 | 4 | Lang Matthew | MYOV | Common Shares | D | 53 615 | 53 615 | ||||||
| 2019-08-27 | 2019-08-26 | 4 | Sablich Kim | MYOV | Stock Option (Right to Buy) | D | 7,78 | 66 130 | 66 130 | |||||
| 2019-08-27 | 2019-08-26 | 4 | Sablich Kim | MYOV | Stock Option (Right to Buy) | D | 24,44 | -66 130 | 0 | |||||
| 2019-08-27 | 2019-08-26 | 4 | Sablich Kim | MYOV | Stock Option (Right to Buy) | D | 7,78 | 133 500 | 133 500 | |||||
| 2019-08-27 | 2019-08-26 | 4 | Sablich Kim | MYOV | Stock Option (Right to Buy) | D | 17,28 | -133 500 | 0 | |||||
| 2019-08-27 | 2019-08-26 | 4 | Sablich Kim | MYOV | Common Shares | D | 37 415 | 67 115 | ||||||
| 2019-08-27 | 2019-08-23 | 4 | Curran Terrie | MYOV | Stock Option (Right to Buy) | D | 7,65 | 58 608 | 58 608 | |||||
| 2019-08-27 | 2019-08-23 | 4 | GUINAN MARK | MYOV | Stock Option (Right to Buy) | D | 7,65 | 58 608 | 58 608 | |||||
| 2019-08-27 | 2019-08-23 | 4 | POTTER MYRTLE S | MYOV | Stock Option (Right to Buy) | D | 7,65 | 58 608 | 58 608 | |||||
| 2019-08-27 | 2019-08-23 | 4 | Sebelius Kathleen | MYOV | Stock Option (Right to Buy) | D | 7,65 | 58 608 | 58 608 | |||||
| 2019-08-27 | 2019-08-23 | 4 | Torti Frank | MYOV | Stock Option (Right to Buy) | D | 7,65 | 58 608 | 58 608 | |||||
| 2019-06-14 | 2019-06-12 | 4 | Sebelius Kathleen | MYOV | Common Shares | D | 8,9600 | 4 500 | 40 | 5 000 | ||||
| 2019-06-14 | 2019-06-12 | 4 | Sebelius Kathleen | MYOV | Common Shares | D | 8,9200 | 300 | 3 | 500 | ||||
| 2019-06-14 | 2019-06-12 | 4 | Sebelius Kathleen | MYOV | Common Shares | D | 8,9300 | 100 | 1 | 200 | ||||
| 2019-06-14 | 2019-06-12 | 4 | Sebelius Kathleen | MYOV | Common Shares | D | 8,9500 | 100 | 1 | 100 | ||||
| 2019-06-13 | 2019-06-04 | 4 | VIKING GLOBAL PERFORMANCE LLC See Footnotes | MYOV | Common Shares, $0.000017727 par value per share | I | 8,2500 | 2 424 242 | 20 000 | 40 765 599 | ||||
| 2019-06-13 | 2019-06-04 | 4 | VIKING GLOBAL INVESTORS LP See Footnotes | MYOV | Common Shares, $0.000017727 par value per share | I | 8,2500 | 2 424 242 | 20 000 | 40 765 599 | ||||
| 2019-06-11 | 2019-06-11 | 4 | KARBE FRANK | MYOV | Common Shares | D | 9,1000 | 8 000 | 73 | 8 000 | ||||
| 2019-06-06 | 2019-06-04 | 4 | QVT Associates GP LLC see fn | MYOV | Common Shares, $0.000017727 par value per share | I | 8,2500 | 2 424 242 | 20 000 | 40 765 599 | ||||
| 2019-06-06 | 2019-06-04 | 4 | Dexxon Holdings Ltd. See footnotes | MYOV | Common Shares, $0.000017727 par value per share | I | 8,2500 | 2 424 242 | 20 000 | 40 765 599 | ||||
| 2019-06-06 | 2019-06-04 | 4 | Machado Patrick | MYOV | Common Shares, $0.000017727 par value per share | I | 8,2500 | 2 424 242 | 20 000 | 40 765 599 | ||||
| 2019-06-06 | 2019-06-04 | 4 | SVF Investments (UK) Ltd See Explanation | MYOV | Common Shares | I | 8,2500 | 2 424 242 | 20 000 | 40 765 599 | ||||
| 2019-06-06 | 2019-06-04 | 4 | Lo Andrew See footnotes | MYOV | Common Shares, $0.000017727 par value per share | I | 8,2500 | 2 424 242 | 20 000 | 40 765 599 | ||||
| 2019-06-06 | 2019-06-04 | 4 | Roivant Sciences Ltd. | MYOV | Common Shares, par value $0.000017727 per share | D | 8,2500 | 2 424 242 | 20 000 | 40 765 599 | ||||
| 2019-04-09 | 2019-04-05 | 4 | Lang Matthew | MYOV | Stock Option (Right to Buy) | D | 24,44 | 152 110 | 152 110 | |||||
| 2019-04-09 | 2019-04-05 | 4 | Sablich Kim | MYOV | Stock Option (Right to Buy) | D | 24,44 | 66 130 | 66 130 | |||||
| 2019-04-09 | 2019-04-05 | 4 | Seely Lynn | MYOV | Stock Option (Right to Buy) | D | 24,44 | 330 660 | 330 660 | |||||
| 2019-04-09 | 2019-04-05 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 24,44 | 132 270 | 132 270 | |||||
| 2019-04-09 | 2019-04-05 | 4 | Arjona Ferreira Juan Camilo | MYOV | Stock Option (Right to Buy) | D | 24,44 | 66 130 | 66 130 | |||||
| 2019-02-20 | 2019-02-15 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Stock | D | 21,1500 | -260 | -5 | 9 740 | ||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 76 682 714 | ||||||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 76 682 714 | ||||||||
| 2019-01-10 | 3 | Viking Global Equities Master Ltd. See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 76 682 714 | ||||||||
| 2018-12-18 | 2018-12-17 | 4 | Sablich Kim | MYOV | Employee Stock Option (Right to Buy) | D | 17,28 | 133 500 | 133 500 | |||||
| 2018-12-18 | 2018-12-17 | 4 | Sablich Kim | MYOV | Common Shares | D | 29 700 | 29 700 | ||||||
| 2018-12-03 | 3 | Sablich Kim | MYOV | Common Shares | D | 0 | ||||||||
| 2018-11-08 | 3 | Torti Frank | MYOV | Common Shares | D | 0 | ||||||||
| 2018-11-08 | 2018-11-06 | 4 | Torti Frank | MYOV | Stock Option (Right to Buy) | D | 22,83 | 45 000 | 45 000 | |||||
| 2018-09-24 | 3 | POTTER MYRTLE S | MYOV | Common Shares | D | 0 | ||||||||
| 2018-09-24 | 2018-09-20 | 4 | POTTER MYRTLE S | MYOV | Stock Option (Right to Buy) | D | 26,17 | 45 000 | 45 000 | |||||
| 2018-09-04 | 2018-08-31 | 4 | Curran Terrie | MYOV | Stock Option (Right to Buy) | D | 24,25 | 22 500 | 22 500 | |||||
| 2018-09-04 | 2018-08-31 | 4 | Sebelius Kathleen | MYOV | Stock Option (Right to Buy) | D | 24,25 | 22 500 | 22 500 | |||||
| 2018-09-04 | 2018-08-31 | 4 | Altmeyer Mark | MYOV | Stock Option (Right to Buy) | D | 24,25 | 22 500 | 22 500 | |||||
| 2018-07-24 | 3 | GUINAN MARK | MYOV | Common Shares | D | 0 | ||||||||
| 2018-07-24 | 2018-07-23 | 4 | GUINAN MARK | MYOV | Stock Option (Right to Buy) | D | 19,71 | 45 000 | 45 000 | |||||
| 2018-06-15 | 2017-11-17 | 4 | Altmeyer Mark | MYOV | Common Shares | D | 13,3800 | 3 500 | 47 | 3 500 | ||||
| 2018-04-18 | 2018-04-16 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 21,87 | 114 690 | 114 690 | |||||
| 2018-04-18 | 2018-04-16 | 4 | Seely Lynn | MYOV | Stock Option (Right to Buy) | D | 21,87 | 248 450 | 248 450 | |||||
| 2018-04-18 | 2018-04-16 | 4 | Lang Matthew | MYOV | Employee Stock Option (Right to Buy) | D | 21,87 | 87 050 | 87 050 | |||||
| 2018-04-18 | 2018-04-16 | 4 | Arjona Ferreira Juan Camilo | MYOV | Employee Stock Option (Right to Buy) | D | 21,87 | 87 050 | 87 050 | |||||
| 2018-04-05 | 2018-04-02 | 4 | VIKING GLOBAL INVESTORS LP See Explanation of Responses | MYOV | Common Shares, $0.000017727 par value per share | I | 20,2700 | 1 110 015 | 22 500 | 38 341 357 | ||||
| 2018-04-04 | 2018-04-02 | 4 | VIKING GLOBAL PERFORMANCE LLC Explanation of Responses | MYOV | Common Shares, $0.000017727 par value per share | I | 20,2700 | 1 110 015 | 22 500 | 38 341 357 | ||||
| 2018-04-04 | 3 | Dexcel Pharma Technologies Ltd. See footnotes | MYOV | Common Shares, $0.000017727 par value per share | I | 74 462 684 | ||||||||
| 2018-04-04 | 3 | Dexcel Pharma Technologies Ltd. See footnotes | MYOV | Common Shares, $0.000017727 par value per share | I | 74 462 684 | ||||||||
| 2018-04-04 | 3 | Dexcel Pharma Technologies Ltd. See footnotes | MYOV | Common Shares, $0.000017727 par value per share | I | 74 462 684 | ||||||||
| 2018-04-04 | 2018-04-02 | 4 | Dexxon Holdings Ltd. See footnotes | MYOV | Common Shares, $0.000017727 par value per share | I | 20,2700 | 1 110 015 | 22 500 | 38 341 357 | ||||
| 2018-04-04 | 2018-04-02 | 4 | Lo Andrew | MYOV | Common Shares, $0.000017727 par value per share | I | 20,2700 | 1 110 015 | 22 500 | 38 341 357 | ||||
| 2018-04-04 | 2018-04-02 | 4 | Machado Patrick | MYOV | Common Shares, $0.000017727 par value per share | I | 20,2700 | 1 110 015 | 22 500 | 38 341 357 | ||||
| 2018-04-04 | 2018-04-02 | 4 | Roivant Sciences Ltd. | MYOV | Common Shares, $0.000017727 par value per share | D | 20,2700 | 1 110 015 | 22 500 | 38 341 357 | ||||
| 2018-04-04 | 2018-04-02 | 4 | SVF Investments (UK) Ltd See Explanation | MYOV | Common Shares | I | 20,2700 | 1 110 015 | 22 500 | 38 341 357 | ||||
| 2018-04-04 | 2018-04-02 | 4 | QVT Associates GP LLC | MYOV | Common Shares, $0.000017727 par value per share | I | 20,2700 | 1 110 015 | 22 500 | 38 341 357 | ||||
| 2018-03-29 | 3 | MILLENNIUM PHARMACEUTICALS INC | MYOV | Common Stock | D | 14 841 250 | ||||||||
| 2018-03-29 | 3 | MILLENNIUM PHARMACEUTICALS INC | MYOV | Common Stock | D | 14 841 250 | ||||||||
| 2018-03-29 | 3 | MILLENNIUM PHARMACEUTICALS INC | MYOV | Common Stock | D | 14 841 250 | ||||||||
| 2018-03-29 | 3 | MILLENNIUM PHARMACEUTICALS INC | MYOV | Common Stock | D | 14 841 250 | ||||||||
| 2018-03-21 | 2018-03-19 | 4 | Takeda Pharmaceuticals International AG By Millennium Pharmaceuticals , Inc. | MYOV | Common Stock | I | 18,6700 | 7 420 625 | 138 543 | 7 420 625 | ||||
| 2018-03-21 | 2018-03-19 | 4 | Takeda Pharmaceuticals International AG | MYOV | Common Stock | D | 18,6700 | -7 420 625 | -138 543 | 0 | ||||
| 2017-10-20 | 2017-08-18 | 4 | Altmeyer Mark | MYOV | Stock Option (Right to Buy) | D | 13,14 | 22 500 | 22 500 | |||||
| 2017-10-20 | 2017-08-18 | 4 | Curran Terrie | MYOV | Stock Option (Right to Buy) | D | 13,14 | 22 500 | 22 500 | |||||
| 2017-10-20 | 2017-08-18 | 4 | DeVeydt Wayne S | MYOV | Stock Option (Right to Buy) | D | 13,14 | 22 500 | 22 500 | |||||
| 2017-10-20 | 2017-08-18 | 4 | Sebelius Kathleen | MYOV | Stock Option (Right to Buy) | D | 13,14 | 22 500 | 22 500 | |||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | MYOV | Common Shares | I | 74 462 684 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | MYOV | Common Shares | I | 74 462 684 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | MYOV | Common Shares | I | 74 462 684 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | MYOV | Common Shares | I | 74 462 684 | ||||||||
| 2017-09-14 | 3 | SVF Investments (UK) Ltd See Explanation | MYOV | Common Shares | I | 74 462 684 | ||||||||
| 2017-08-17 | 2017-08-15 | 4 | Arjona Ferreira Juan Camilo | MYOV | Employee Stock Option (Right to Buy) | D | 10,60 | 260 000 | 260 000 | |||||
| 2017-08-17 | 2017-08-15 | 4 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 10 000 | 10 000 | ||||||
| 2017-08-09 | 3 | Arjona Ferreira Juan Camilo | MYOV | Common Shares | D | 0 | ||||||||
| 2017-07-18 | 3 | Lang Matthew | MYOV | Common Stock | D | 0 | ||||||||
| 2017-07-18 | 2017-07-17 | 4 | Lang Matthew | MYOV | Employee Stock Option (Right to Buy) | D | 11,30 | 310 000 | 310 000 | |||||
| 2017-07-10 | 3 | Shabet Rose Sharon See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2017-07-10 | 3 | Shabet Rose Sharon See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2017-06-02 | 2017-05-31 | 4 | Seely Lynn | MYOV | Common Shares | D | 564 111 | 1 692 333 | ||||||
| 2017-05-17 | 2017-05-15 | 4 | Sebelius Kathleen | MYOV | Stock Option (Right to Buy) | D | 12,68 | 11 154 | 11 154 | |||||
| 2017-05-17 | 2017-05-15 | 4 | Altmeyer Mark | MYOV | Stock Option (Right to Buy) | D | 12,68 | 11 154 | 11 154 | |||||
| 2017-05-17 | 2017-05-15 | 4 | Curran Terrie | MYOV | Stock Option (Right to Buy) | D | 12,68 | 11 154 | 11 154 | |||||
| 2017-05-17 | 2017-05-15 | 4 | DeVeydt Wayne S | MYOV | Stock Option (Right to Buy) | D | 12,68 | 11 154 | 11 154 | |||||
| 2017-05-17 | 2017-05-15 | 4 | KARBE FRANK | MYOV | Stock Option (Right to Buy) | D | 12,68 | 200 000 | 200 000 | |||||
| 2017-05-17 | 2017-05-15 | 4 | Seely Lynn | MYOV | Stock Option (Right to Buy) | D | 12,68 | 400 000 | 400 000 | |||||
| 2017-04-19 | 2017-04-17 | 4 | Takeda Pharmaceuticals International AG | MYOV | Warrant to Purchase Common Shares | D | -4 432 | 0 | ||||||
| 2017-04-19 | 2017-04-17 | 4 | Takeda Pharmaceuticals International AG | MYOV | Common Shares | D | 4 432 | 7 420 625 | ||||||
| 2017-03-24 | 2017-03-15 | 4 | Takeda Pharmaceuticals International AG | MYOV | Warrant to Purchase Common Shares | D | -13 091 | 0 | ||||||
| 2017-03-24 | 2017-03-15 | 4 | Takeda Pharmaceuticals International AG | MYOV | Common Shares | D | 13 091 | 7 416 193 | ||||||
| 2017-03-24 | 2017-02-15 | 4 | Takeda Pharmaceuticals International AG | MYOV | Warrant to Purchase Common Shares | D | -6 845 | 0 | ||||||
| 2017-03-24 | 2017-02-15 | 4 | Takeda Pharmaceuticals International AG | MYOV | Common Shares | D | 6 845 | 7 403 102 | ||||||
| 2017-03-13 | 2017-01-17 | 4 | Takeda Pharmaceuticals International AG | MYOV | Warrant to Purchase Common Shares | D | -5 727 | 0 | ||||||
| 2017-03-13 | 2017-01-17 | 4 | Takeda Pharmaceuticals International AG | MYOV | Common Shares | D | 5 727 | 7 396 257 | ||||||
| 2017-03-13 | 2016-12-15 | 4 | Takeda Pharmaceuticals International AG | MYOV | Warrant to Purchase Common Shares | D | -22 141 | 0 | ||||||
| 2017-03-13 | 2016-12-15 | 4 | Takeda Pharmaceuticals International AG | MYOV | Common Shares | D | 22 141 | 7 390 530 | ||||||
| 2016-11-17 | 3 | Curran Terrie | MYOV | Common Shares | D | 0 | ||||||||
| 2016-11-17 | 2016-11-15 | 4 | Curran Terrie | MYOV | Stock Option (Right to Buy) | D | 11,30 | 33 846 | 33 846 | |||||
| 2016-11-03 | 2016-11-01 | 4 | Takeda Pharmaceuticals International AG | MYOV | Warrant to Purchase Common Shares | D | -1 977 269 | 0 | ||||||
| 2016-11-03 | 2016-11-01 | 4 | Takeda Pharmaceuticals International AG | MYOV | Common Shares | D | 1 977 269 | 7 368 389 | ||||||
| 2016-10-27 | 3/A | Takeda Pharmaceuticals International AG | MYOV | Common Shares | D | 5 391 120 | ||||||||
| 2016-10-27 | 3 | Lo Andrew See footnote. | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-27 | 3 | Lo Andrew See footnote. | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Sundheim Daniel S. See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Sundheim Daniel S. See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Sundheim Daniel S. See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Sundheim Daniel S. See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Sundheim Daniel S. See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Sundheim Daniel S. See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Sundheim Daniel S. See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Sundheim Daniel S. See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Viking Long Fund Master Ltd. See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Viking Long Fund Master Ltd. See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Viking Long Fund Master Ltd. See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Viking Long Fund Master Ltd. See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Viking Long Fund Master Ltd. See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Viking Long Fund Master Ltd. See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Viking Long Fund Master Ltd. See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Roivant Sciences Ltd. | MYOV | Common Shares, $0.00001 par value per share | D | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Roivant Sciences Ltd. | MYOV | Common Shares, $0.00001 par value per share | D | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Machado Patrick See footnote. | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Machado Patrick See footnote. | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Oren Dan See footnote. | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Oren Dan See footnote. | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Oren Dan See footnote. | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | Seely Lynn | MYOV | Common Shares | D | 2 256 444 | ||||||||
| 2016-10-26 | 3 | Seely Lynn | MYOV | Common Shares | D | 2 256 444 | ||||||||
| 2016-10-26 | 3 | Romeo Marianne L. | MYOV | Common Shares | D | 0 | ||||||||
| 2016-10-26 | 3 | DeVeydt Wayne S | MYOV | Common Shares | D | 0 | ||||||||
| 2016-10-26 | 3 | MANCHESTER KEITH S | MYOV | Common Shares | I | 0 | ||||||||
| 2016-10-26 | 3 | Ramaswamy Vivek | MYOV | Common Shares | I | 0 | ||||||||
| 2016-10-26 | 3 | Sebelius Kathleen | MYOV | Common Shares | D | 0 | ||||||||
| 2016-10-26 | 3 | Takeda Pharmaceuticals International AG | MYOV | Common Shares | D | 10 782 240 | ||||||||
| 2016-10-26 | 3 | Takeda Pharmaceuticals International AG | MYOV | Common Shares | D | 10 782 240 | ||||||||
| 2016-10-26 | 3 | QVT Fund V LP See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | QVT Fund V LP See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | QVT Fund V LP See Explanation of Responses | MYOV | Common Shares, $0.00001 par value per share | I | 74 462 684 | ||||||||
| 2016-10-26 | 3 | KARBE FRANK | MYOV | Common Shares | D | 0 | ||||||||
| 2016-10-26 | 3 | Altmeyer Mark | MYOV | Common Shares | D | 0 |
P
Otwarty rynek lub prywatny zakup niepochodnych lub pochodnych papierów wartościowych
S
Otwarty rynek lub prywatna sprzedaż niepochodnych lub pochodnych papierów wartościowych
A
Grant, nagroda lub inne nabycie papierów wartościowych od spółki (np. opcja)
C
Konwersja instrumentu pochodnego
D
Sprzedaż lub przeniesienie papierów wartościowych z powrotem do spółki
F
Zapłata ceny wykonania lub zobowiązania podatkowego z wykorzystaniem części papierów wartościowych otrzymanych od spółki
G
Darowizna papierów wartościowych przez lub na rzecz insidera
K
Swapy kapitałowe i podobne transakcje zabezpieczające
M
Wykonanie lub konwersja pochodnego papieru wartościowego otrzymanego od spółki (takiego jak opcja)
V
Transakcja dobrowolnie zgłoszona na Formularzu 4
J
Inne (wraz z przypisem opisującym transakcję)
